Matthew Lang insider trades

Open-market stock purchases and sales by Matthew Lang, COO & GC at Structure Therapeutics Inc, from SEC Form 4 filings since Jul 17, 2017.

Recent trades

DateStockTradeValue
Apr 15, 2026GPCR Structure Therapeutics IncBought (not open market)—
Apr 15, 2026GPCR Structure Therapeutics IncBought (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)—
Nov 13, 2025MTSR Metsera, IncBought (not open market)—
Nov 13, 2025MTSR Metsera, IncSold (not open market)$1.4M
Nov 13, 2025MTSR Metsera, IncSold (not open market)$5.6M

Companies traded

  • GPCR Structure Therapeutics Inc: other filings, last Apr 15, 2026
  • MTSR Metsera, Inc: other filings, last Nov 13, 2025
  • LYEL Lyell Immunopharma, Inc: other filings, last Feb 10, 2025
  • MYOV Myovant Sciences Ltd: 23 sales, last Mar 10, 2023

Get free alerts when Matthew Lang files a new trade →